| Aranesp |
103951 |
044 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
100MCG/0.5ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
045 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
150MCG/0.3ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
046 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
200MCG/0.4ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
047 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
300MCG/0.6ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
048 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
500MCG/1ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Gardasil |
125126 |
001 |
351(a) |
Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant |
Injection |
Intramuscular |
120MCG L1 PROTEIN FROM HPV 6, 11, 16 AND 18 UG/.5ML |
Syringe |
2006/06/08
|
Merck Sharp & Dohme LLC |
Disc |
Licensed |
|
N/A |
| Omnitrope |
021426 |
001 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
5.8MG |
Multi-Dose Vial |
2006/05/30
|
Sandoz Inc. |
Rx |
Licensed |
N/A |
N/A |
| Omnitrope |
021426 |
002 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
1.5MG |
Single-Dose Vial |
2006/05/30
|
Sandoz Inc. |
Disc |
Licensed |
N/A |
N/A |
| Zostavax |
125123 |
001 |
351(a) |
Zoster Vaccine Live |
For Injection |
Subcutaneous |
0.65ML |
Single-Dose Vial |
2006/05/25
|
Merck Sharp & Dohme LLC |
Disc |
Licensed |
|
N/A |
| Myozyme |
125141 |
001 |
351(a) |
alglucosidase alfa |
For Injection |
Intravenous |
50MG |
Single-Dose Vial |
2006/04/28
|
Genzyme Corporation |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Advate |
125063 |
005 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2006/04/12
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Rotateq |
125122 |
001 |
351(a) |
Rotavirus Vaccine, Live, Oral, Pentavalent |
Suspension |
Oral |
2.2X10E6 IU |
Tube |
2006/02/03
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Hepagam B |
125035 |
001 |
351(a) |
Hepatitis B Immune Globulin (Human) |
Injection |
Intramuscular |
>1560IU/5ML |
Single-Dose Vial |
2006/01/27
|
Kamada Ltd. |
Rx |
Licensed |
|
N/A |
| Hepagam B |
125035 |
002 |
351(a) |
Hepatitis B Immune Globulin (Human) |
Injection |
Intramuscular |
>312IU/ML |
Single-Dose Vial |
2006/01/27
|
Kamada Ltd. |
Rx |
Licensed |
|
N/A |
| Vivaglobin |
125115 |
001 |
351(a) |
Immune Globulin Subcutaneous (Human) |
For Injection |
Subcutaneous |
160MG/ML |
Vial |
2006/01/09
|
CSL Behring GmbH |
Disc |
Voluntarily Revoked |
|
|
| Elitek |
103946 |
002 |
351(a) |
rasburicase |
For Injection |
Intravenous |
7.5MG |
Single-Dose Vial |
2006/01/06
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
| Orencia |
125118 |
001 |
351(a) |
abatacept |
For Injection |
Intravenous |
250MG |
Single-Dose Vial |
2005/12/23
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Apidra |
021629 |
002 |
351(a) |
insulin glulisine |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Multi-Dose Cartridge |
2005/12/20
|
Sanofi-Aventis U.S. LLC |
Disc |
Licensed |
N/A |
N/A |
| Iplex |
021884 |
001 |
351(a) |
mecasermin rinfabate |
Injection |
Subcutaneous |
36MG/0.6ML (60MG/ML) |
Single-Dose Vial |
2005/12/12
|
Insmed Incorporated |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Hylenex recombinant |
021859 |
001 |
351(a) |
hyaluronidase human |
Injection |
Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous |
150UNITS/ML |
Single-Dose Vial |
2005/12/02
|
Halozyme Therapeutics, Inc. |
Rx |
Licensed |
N/A |
N/A |